aposcience.at bewertung und analyse
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Aposcience AG: the secretome |
| Description | Aposcience AG – the secretome Home Contact Company Mission Statement Management Partners Technology Overview Pre-Clinical GMP Manufacturing Clinical Klinische Studie Clinical Trial New |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 81.19.145.154 |
| Location | Austria |
Mehr zu entdecken
aposcience.at bewertung
|
Euro€1,102
Zuletzt aktualisiert: 2022-10-20 12:35:40
aposcience.at hat Semrush globalen Rang von 35,012,750. aposcience.at hat einen geschätzten Wert von € 1,102, basierend auf seinen geschätzten Werbeeinnahmen. aposcience.at empfängt jeden Tag ungefähr 551 einzelne Besucher. Sein Webserver befindet sich in Austria mit der IP-Adresse 81.19.145.154. Laut SiteAdvisor ist aposcience.at sicher zu besuchen. |
Verkehr & Wertschätzungen
| Kauf-/Verkaufswert | Euro€1,102 |
| Tägliche Werbeeinnahmen | Euro€22,591 |
| Monatlicher Anzeigenumsatz | Euro€7,714 |
| Jährliche Werbeeinnahmen | Euro€551 |
| Tägliche eindeutige Besucher | 551 |
| Hinweis: Alle Traffic- und Einnahmenwerte sind Schätzungen. | |
DNS Records
| Host | Type | TTL | Data |
| aposcience.at. | A | 3600 | IP: 81.19.145.154 |
| aposcience.at. | NS | 21600 | NS Record: ns1.world4you.at. |
| aposcience.at. | NS | 21600 | NS Record: ns2.world4you.at. |
| aposcience.at. | MX | 3600 | MX Record: 10 mail.aposcience.at. |
HtmlToTextCheckTime:2022-10-20 12:35:40
| Home Contact Company Mission Statement Management Partners Technology Overview Pre-Clinical GMP Manufacturing Clinical Klinische Studie Clinical Trial News News Archive Key Publications Events Focus Wound Healing Focus Myocardial Infarction The APOSEC Story Aposcience AG – the secretome company Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be functionally restored, rather than just repaired. The company’s proprietary technology is based on secretomes of white blood cells (peripheral blood mononuclear cells [PBMCs]). Aposcience develops its products for the treatment of impaired wound healing (e.g., diabetic ulcers and deep skin burn injury) and internal diseases that are related to ischemia induced inflammation (acute and chronic myocardial infarction, stroke, spinal cord injury). Latest News |
HTTP Headers
HTTP/1.1 302 Found Date: Thu, 24 Feb 2022 09:28:27 GMT Server: Apache Location: http://www.aposcience.at/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Thu, 24 Feb 2022 09:28:27 GMT Server: Apache Set-Cookie: fe_typo_user=c2d4bb0ccdc55c3caa3ce6ab744d0cc3; path=/ Content-Type: text/html; charset=utf-8 |